These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36302483)

  • 1. Chitosan modified 5-fluorouracil nanostructured lipid carriers for treatment of diabetic retinopathy in rats: A new dimension to an anticancer drug.
    Sharma DS; Wadhwa S; Gulati M; Kumar B; Chitranshi N; Gupta VK; Alrouji M; Alhajlah S; AlOmeir O; Vishwas S; Khursheed R; Saini S; Kumar A; Parveen SR; Gupta G; Zacconi F; Chellappan DK; Morris A; Loebenberg R; Dua K; Singh SK
    Int J Biol Macromol; 2023 Jan; 224():810-830. PubMed ID: 36302483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical characterization and bioavailability assessment of 5-fluorouracil-based nanostructured lipid carrier (NLC): In vitro drug release, Hemolysis, and permeability modulation.
    Mainuddin ; Kumar A; Ratnesh RK; Singh J; Dumoga S; Sharma N; Jindal A
    Med Oncol; 2024 Mar; 41(5):95. PubMed ID: 38526657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repositioning of Itraconazole for the Management of Ocular Neovascularization Through Surface-Modified Nanostructured Lipid Carriers.
    Selvaraj K; Kuppusamy G; Krishnamurthy J; Mahalingam R; Singh SK; Gulati M
    Assay Drug Dev Technol; 2019; 17(4):178-190. PubMed ID: 30835139
    [No Abstract]   [Full Text] [Related]  

  • 4. Eudragit S-100 Surface Engineered Nanostructured Lipid Carriers for Colon Targeting of 5-Fluorouracil: Optimization and In Vitro and In Vivo Characterization.
    Borderwala K; Rathod S; Yadav S; Vyas B; Shah P
    AAPS PharmSciTech; 2021 Aug; 22(6):216. PubMed ID: 34386888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
    Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M
    Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson's disease: interplay between nuclear factor-kappa β and cathepsin B.
    Hassan DM; El-Kamel AH; Allam EA; Bakr BA; Ashour AA
    Drug Deliv Transl Res; 2024 Feb; 14(2):400-417. PubMed ID: 37598133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
    Zafar A
    J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
    Rathod VR; Shah DA; Dave RH
    Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition.
    Rapalli VK; Sharma S; Roy A; Singhvi G
    Colloids Surf B Biointerfaces; 2021 Oct; 206():111945. PubMed ID: 34216849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex Vivo and in Vivo Evaluation of the Effect of Coating a Coumarin-6-Labeled Nanostructured Lipid Carrier with Chitosan-N-acetylcysteine on Rabbit Ocular Distribution.
    Liu D; Li J; Cheng B; Wu Q; Pan H
    Mol Pharm; 2017 Aug; 14(8):2639-2648. PubMed ID: 28664726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy.
    Alam T; Pandit J; Vohora D; Aqil M; Ali A; Sultana Y
    Expert Opin Drug Deliv; 2015 Feb; 12(2):181-94. PubMed ID: 25164097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
    Li J; Tan G; Cheng B; Liu D; Pan W
    Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
    Wang W; Chen L; Huang X; Shao A
    AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of Chitosan-Coated Piperine NLCs: Optimization, In Vitro Characterization, and In Vivo Preclinical Assessment.
    Zafar A; Alruwaili NK; Imam SS; Alsaidan OA; Alharbi KS; Yasir M; Elmowafy M; Mohammed EF; Al-Oanzi ZH
    AAPS PharmSciTech; 2021 Aug; 22(7):231. PubMed ID: 34477999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented ocular uptake and anti-inflammatory efficacy of decorated Genistein-loaded NLCs incorporated in in situ gel.
    Elmanawy MA; Boraie N; Bakr BA; Makled S
    Int J Pharm; 2024 Sep; 662():124508. PubMed ID: 39053680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructured lipid carrier-incorporated gel for efficient topical delivery of fluconazole.
    Patil A; Tuencar V; Gadad A; Dandagi P; Masareddy R
    Ther Deliv; 2021 Aug; 12(8):565-574. PubMed ID: 34187177
    [No Abstract]   [Full Text] [Related]  

  • 20. Dual Drug Loaded Lipid Nanocarrier Formulations for Topical Ocular Applications.
    Youssef AAA; Dudhipala N; Majumdar S
    Int J Nanomedicine; 2022; 17():2283-2299. PubMed ID: 35611213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.